Indivior enjoys a strong recovery as it targets primary US listing
Shares in Indivior (INDV) are up 36% year-to-date. The latest catalyst for the opioid-use disorder treatment specialist came in the form of 2023 sales and profit towards the top end of expectations and guidance for stronger than forecast profit growth in 2024 (22 February).
Also giving the shares a boost was the news the company plans to move its primary stock exchange listing to the US where it may achieve a higher valuation. The company listed its shares on Nasdaq in 2023.
At £17.63, the share are below the £20 mark they traded at in February 2023 when the firm took an unexpected $290 million provision to cover legacy litigation cases.
In October 2023, Indivior agreed to pay $385 million to settle certain some cases, resolving claims brought by direct purchasers that the firm suppressed competition for its opioid addiction treatment Suboxone.
Management expects 2024 net revenue to grow by 18% at the midpoint of the range ($1.29 billion) and to generate an adjusted operating profit of between $330 million and $380 million.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Editor's View
Feature
Great Ideas
News
- Indivior enjoys a strong recovery as it targets primary US listing
- Halfords skids lower on weak demand and wet weather woe
- Is Adobe primed for an upside surprise?
- Competitive pressures are piling up for Pets at Home
- Will the Reddit initial public offering live up to investors’ hopes?
- Budget 2024: British ISA launched, booze duty freeze lifts pub stocks